Genomic quasispecies associated with the initiation of infection and disease in ponies experimentally infected with equine infectious anemia virus

Journal of Virology

Volumn 70, Issue 6, 1996, Pages 3346-3354

  Lichtenstein, Drew L ^a   Issel, Charles J ^b   Montelaro, Ronald C ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS RNA;

ANEMIA; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; EQUINE INFECTIOUS ANEMIA VIRUS; HORSE; HORSE DISEASE; LONG TERMINAL REPEAT; NONHUMAN; PRIORITY JOURNAL; VIRUS GENOME;

EID: 0029888086     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.70.6.3346-3354.1996     Document Type: Article

References (44)

1. Alexandersen, S., and S. Carpenter. 1991. Characterization of variable regions in the envelope and S3 open reading frame of equine infectious anemia virus. J. Virol. 65:4255-4262.
2. Baier, M., M. T. Dittmar, K. Cichutek, and R. Kurth. 1991. Development in vivo of genetic variability of simian immunodeficiency virus. Proc. Natl. Acad. Sci. USA 88:8126-8130.
3. Ball, J. M., K. E. Rushlow, C. J. Issel, and R. C. Montelaro. 1992. Detailed mapping of the antigenicity of the surface unit glycoprotein of equine infectious anemia virus by using synthetic peptide strategies. J. Virol. 66:732-742.
4. Bosch, M. L., A. C. Andeweg, R. Schipper, and M. Kenter. 1994. Insertion of N-linked glycosylation sites in the variable regions of the human immunodeficiency virus type 1 surface glycoprotein through AAT triplet reiteration. J. Virol. 68:7566-7569.
5. Burns, D. P., and R. C. Desrosiers. 1991. Selection of genetic variants of simian immunodeficiency virus in persistently infected rhesus monkeys. J. Virol. 65:1843-1854.
6. Carpenter, S., S. Alexandersen, M. J. Long, S. Ferryman, and B. Chesebro. 1991. Identification of a hypervariable region in the long terminal repeat of equine infectious anemia virus. J. Virol. 65:1605-1610.
7. Carvalho, M., and D. Derse. 1993. The PU.l/Spi-1 proto-oncogene is a transcriptional regulator of a lentivirus promoter. J. Virol. 67:3885-3890.
8. Couillin, I., P. B. Culmann, E. Gomard, J. Choppin, J. P. Levy, J. G. Guillet, and S. Saragosti. 1994. Impaired cytotoxic T lymphocyte recognition due to genetic variations in the main immunogenic region of the HIV-1 nef protein. J. Exp. Med. 180:1129-1134.
9. SM-related HIV-2 in west Africa. Nature (London) 358:495-499.
10. Genetics Computer Group. 1994. Program manual for the Wisconsin Package. Genetics Computer Group, Madison, Wis.
11. Grund, C. H., P. R. Calkins, and R. C. Montelaro. Quantification of equine infectious anemia virus (EIAV) infectivity by an immunological plaque assay. Unpublished data.
12. Hahn, B. H., G. M. Shaw, M. E. Taylor, R. R. Redfield, P. D. Markham, S. Z. Salahuddin, S. F. Wong, R. C. Gallo, E. S. Parks, and W. P. Parks. 1986. Genetic variation in HTLV-III/LAV over time in patients with AIDS or at risk for AIDS. Science 232:1548-1553.
13. Ho, D. D., A, U. Neumann, A. S. Perelson, W. Chen, J. M. Leonard, and M. Markowitz. 1995. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature (London) 373:123-126.
14. Hussain, K. A., C. J. Issel, K. L. Schnorr, P. M. Rwambo, and R. C. Montelaro. 1987. Antigenic analysis of equine infectious anemia virus (EIAV) variants by using monoclonal antibodies: epitopes of glycoprotein gp90 of EIAV stimulate neutralizing antibodies. J. Virol. 61:2956-2961.
15. Johnson, P. R., T. E. Hamm. S. Goldstein, S. Kitov, and V. M. Hirsch. 1991. The genetic fate of molecularly cloned simian immunodeficiency virus in experimentally infected macaques. Virology 185:217-228.
16. Kono, Y., K. Kobayashi, and Y. Fukunaga. 1973. Antigenic drift of equine infectious anemia virus in chronically infected horses. Arch. Virol. 41:1-10.
17. Koup, R. A., J. T. Safrit, Y. Cao, C. A. Andrews, G. McLeod, W. Borkowsky, C. Farthing, and D. D. Ho. 1994. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. J. Virol. 68:4650-4655.
18. Lichtenstein, D. L., K. E. Rushlow, R. F. Cook, M. L. Raabe, C. J. Swardson, G. J. Kociba, C. J. Issel, and R. C. Montelaro. 1995. Replication in vitro and in vivo of an equine infectious anemia virus mutant deficient in dUTPase activity. J. Virol. 69:2881-2888.
19. Malmquist, W. A., D. Barnett, and C. S. Becvar. 1973. Production of equine infectious anemia antigen in a persistently infected cell line. Arch. Virol. 42:361-370.
20. mac. J. Virol. 67:6047-6055.
21. Maury, W. 1994. Monocyte maturation controls expression of equine infectious anemia virus. J. Virol. 68:6270-6279.
22. McNearney, T., Z. Hornickova, R. Markham, A. Birdwell, M. Arens, A. Saah, and L. Ratner. 1992. Relationship of human immunodeficiency virus type 1 sequence heterogeneity to stage of disease. Proc. Natl. Acad. Sci. USA 89:10247-10251.
23. Meyerhans, A., R. Cheynier, J. Albert, M. Seth, S. Kwok, J. Sninsky, M. L. Morfeldt, B. Asjo, and H. S. Wain. 1989. Temporal fluctuations in HIV quasispecies in vivo are not reflected by sequential HIV isolations. Cell 58:901-910.
24. Montelaro, R. C., J. M. Ball, and K. E. Rushlow. 1993. Equine retroviruses, p. 257-360. In J. A. Levy (ed.), The Retroviridae. vol. 2. Plenum Press, New York.
25. Montelaro, R. C., B. Parekh, A. Orrego, and C. J. Issel. 1984. Antigenic variation during persistent infection by equine infectious anemia virus, a retrovirus. J. Biol. Chem. 259:10539-10544.
26. smmPBj variant. J. Virol. 67:2466-2474.
27. Orrego, A., C. J. Issel, R. C. Montelaro, and W. J. Adams. 1982. Virulence and in vitro growth of a cell-adapted strain of equine infectious anemia virus after serial passage in ponies. Am. J. Vet. Res. 43:1555-1560.
28. Overbaugh, J., L. M. Rudensey, M. D. Papenhausen, R. E. Benveniste, and W. R. Morton. 1991. Variation in simian immunodeficiency virus env is confined to V1 and V4 during progression to simian AIDS. J. Virol. 65: 7025-7031.
29. Payne, S., B. Parekh, R. C. Montelaro, and C. J. Issel. 1984. Genomic alterations associated with persistent infections by equine infectious anaemia virus, a retrovirus. J. Gen. Virol. 65:1395-1399.
30. Payne, S. L., F. D. Fang, C. P. Liu, B. R. Dhruva, P. Rwambo, C. J. Issel, and R. C. Montelaro. 1987. Antigenic variation and lentivirus persistence: variations in envelope gene sequences during EIAV infection resemble changes reported for sequential isolates of HIV. Virology 161:321-331.
31. Payne, S. L., J. Rausch, K. Rushlow, R. C. Montelaro, C. Issel, M. Flaherty, S. Perry, D. Sellon, and F. Fuller. 1994. Characterization of infectious molecular clones of equine infectious anaemia virus. J. Gen. Virol. 75:425-429.
32. Payne, S. L., K. Rushlow, B. R. Dhruva, C. J. Issel, and R. C. Montelaro. 1989. Localization of conserved and variable antigcnic domains of equine infectious anemia virus envelope glycoproteins using recombinant env-encoded protein fragments produced in Escherichia coli Virology 172:609-615.
33. Payne, S. L., O. Salinovich, S. M. Nauman, C. J. Issel, and R. C. Montelaro. 1987. Course and extent of variation of equine infectious anemia virus during parallel persistent infections. J. Virol. 61:1266-1270.
34. Perry, S. T., M. T. Flaherty, M. J. Kelley, D. L. Clabough, S. R. Tronick, L. Coggins, L. Whetter, C. R. Lengel, and F. Fuller. 1992. The surface envelope protein gene region of equine infectious anemia virus is not an important determinant of tropism in vitro. J. Virol. 66:4085-4097.
35. Rushlow, K., K. Olsen, G. Stiegler, S. L. Payne, R. C. Montelaro, and C. J. Issel. 1986. Lentivirus genomic organization: the complete nucleotide sequence of the env gene region of equine infectious anemia virus. Virology 155:309-321.
36. Rwambo, P. M., C. J. Issel, W. J. Adams, K. A. Hussain, M. Miller, and R. C. Montelaro. 1990. Equine infectious anemia virus (EIAV) humoral responses of recipient ponies and antigenic variation during persistent infection. Arch. Virol. 111:199-212.
37. Rwambo, P. M., C. J. Issel, K. A. Hussain, and R. C. Montelaro. 1990. In vitro isolation of a neutralization escape mutant of equine infectious anemia virus (EIAV). Arch. Virol. 111:275-280.
38. Salinovich, O., S. L. Payne, R. C. Montelaro, K. A. Hussain, C. J. Issel, and K. L. Schnorr. 1986. Rapid emergence of novel antigenic and genetic variants of equine infectious anemia virus during persistent infection. J. Virol. 57:71-80.
39. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
40. Sanger, F., S. Nicklen, and A. R. Coulson. 1977. DNA sequencing with chain terminating inhibitors. Proc. Natl. Acad. Sci. USA 74:5463-5467.
41. Tabor, S., and C. C. Richardson. 1987. DNA sequence analysis with a modified bacteriophage T7 DNA polymerase. Proc. Natl. Acad. Sci. USA 84:1467-1471.
42. Vartanian, J. P., A. Meyerhans, B. Asjo, and S. Wain-Hobson. 1991. Selection, recombination, and G→A hypermutation of human immunodeficiency virus type 1 genomes. J. Virol. 65:1779-1788.
43. Wain-Hobson, S., P. Sonigo, M. Guyader, A. Gazit, and M. Henry. 1995. Erratic G→A hypermutation within a complete caprine arthritis-encephalitis virus (CAEV) provirus. Virology 209:297-303.
44. Wei, X., S. K. Ghosh, M. E. Taylor, V. A. Johnson, E. A. Emini, P. Deutsch, J. D. Lifson, S. Bonhoeffer, M. A. Nowak, B. H. Hahn, M. S. Saag, and G. M. Shaw. 1995. Viral dynamics in human immunodeficiency virus type 1 infection. Nature (London) 373:117-122.